GCBP

• Eun-chul Huh, Ph.D President, Chief Executive Officer

  Dr. Eun-chul Huh has led GC Biopharma as President and CEO since 2015, overseeing steady growth in both domestic and international markets. Under his leadership, the company has strengthened its strategic investments and R&D capabilities. With a Ph.D. in Food Engineering from Cornell University, Dr. Huh began his career at the Mogam Institute for Biomedical Research and went on to hold key roles in GC Biopharma’s Strategic Planning Office. His career trajectory has provided him with extensive expertise in research and management, including a pivotal role as the Chief Technology Officer (CTO) and Head of Strategic Planning, where he was responsible for driving innovation in R&D, sales, and production.

Executive Director

• Jae-Wook Jeong, Ph.DHead of Research and Development

  Dr. Jaeuk Jeong leads GC Biopharma’s R&D division, with a focus on advancing the company’s global leadership in developing blood products, vaccines, and innovative therapies. A seasoned expert with a Ph.D. in Organic Chemistry from Purdue University, Dr. Jeong completed his postdoctoral research at The Scripps Research Institute. He spent over two decades at GSK as a GSK Fellow and Scientific Leader before joining GC Biopharma in 2020. Prior to his current role, he served as Director of the Mogam Institute for Biomedical Research, where he spearheaded cutting-edge drug development initiatives.

• Woong Shin, MSHead of Quality Management

  With over 20 years of experience in vaccine development and production, Woong Shin has been committed to elevating GC Biopharma’s quality standards since 2022. As Head of Quality Management, he leads the company’s efforts in rigorous quality control and continuous improvement, supporting the prevention and treatment of diseases through high-quality pharmaceuticals.